Psychiatr. pro Praxi, 2009; 10(2): 72-75

Antidepressants in the treatment of bipolar depression

MUDr. Tomáš Novák, MUDr. Martin Bareš
Psychiatrické centrum Praha, 3. LF UK, Praha

The use of antidepressants in the treatment of bipolar disorder remains controversial. Despite the frequent use in clinical practice, the

fundamental questions regarding the efficacy and safety of antidepressants in both acute and long-term treatment of bipolar disorder

have not yet been satisfactorily answered. The article offers a current view of the place of antidepressants in the treatment of bipolar

depression, including general recommendations for clinical practice.

Keywords: bipolar depression, antidepressants, switch to mania.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novák T, Bareš M. Antidepressants in the treatment of bipolar depression. Psychiatr. praxi. 2009;10(2):72-75.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Manning JS. Burden of illness in bipolar depression. Prim Care Companion J Clin Psychiatry 2005; 67(6): 259-267. Go to original source... Go to PubMed...
    2. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537. Go to original source... Go to PubMed...
    3. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269. Go to original source... Go to PubMed...
    4. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228. Go to original source... Go to PubMed...
    5. Frye MA, Yatham LN, Calabrese JR, et al. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry 2006; 67(11): 1721-1728. Go to original source... Go to PubMed...
    6. Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a doubleblind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006; 26: 600-609. Go to original source... Go to PubMed...
    7. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088. Go to original source... Go to PubMed...
    8. Yatham LN, Kennedy SH, O'Donovan C, et al; Guidelines Group, CANMAT. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 2006; 8(6): 721-739. Go to original source... Go to PubMed...
    9. Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008; 10(2): 323-333. Go to original source... Go to PubMed...
    10. Thase ME, Jonas A, Khan A, et al. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol 2008; 28(1): 13-20. Go to original source... Go to PubMed...
    11. Mitchell PB, Goodwin GM, Johnson GF, et al. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 2008; 10(2): 144-152. Go to original source... Go to PubMed...
    12. Phelps J, Angst J, Katzow J, et al. Validity and utility of bipolar spectrum models. Bipolar Disord 2008; 10(2): 179-193. Go to original source... Go to PubMed...
    13. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161: 1537-1547. Go to original source... Go to PubMed...
    14. Salvi V, Fagiolini A, Swartz HA, et al. The use of antidepressants in bipolar disorder. J Clin Psychiatry 2008; 69(8): 1307-1318. Go to original source... Go to PubMed...
    15. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722. Go to original source... Go to PubMed...
    16. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 2007; 164(9): 1348-1355. Go to original source... Go to PubMed...
    17. Bond DJ, Noronha MM, Kauer-Sant´Anna M, et al. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder. A systematic review and meta-analysis. J Clin Psychiatry 2008 (ahead of print, pii: ej08r04168). Go to original source... Go to PubMed...
    18. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 2008; 118(5): 347-356. Go to original source... Go to PubMed...
    19. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003; 160(7): 1252-1262. Go to original source... Go to PubMed...
    20. Benazzi F. Bipolar disorder: focus on bipolar II disorder and mixed depression. Lancet 2007; 369: 935-945. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.